Procter & Gamble Company (The) (PG) Shares Sold by Sharkey Howes & Javer

Sharkey Howes & Javer reduced its position in Procter & Gamble Company (The) (NYSE:PG) by 23.5% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,625 shares of the company’s stock after selling 500 shares during the period. Sharkey Howes & Javer’s holdings in Procter & Gamble Company (The) were worth $142,000 as of its most recent filing with the SEC.

A number of other institutional investors also recently modified their holdings of PG. Cypress Wealth Advisors LLC increased its position in Procter & Gamble Company (The) by 2.5% in the fourth quarter. Cypress Wealth Advisors LLC now owns 14,731 shares of the company’s stock worth $1,239,000 after buying an additional 361 shares in the last quarter. Shepherd Financial Partners LLC acquired a new position in Procter & Gamble Company (The) during the fourth quarter worth about $733,000. Summit Global Investments acquired a new position in Procter & Gamble Company (The) during the fourth quarter worth about $4,371,000. United Capital Financial Advisers LLC increased its position in Procter & Gamble Company (The) by 3.9% in the fourth quarter. United Capital Financial Advisers LLC now owns 679,532 shares of the company’s stock worth $57,135,000 after buying an additional 25,816 shares in the last quarter. Finally, Cigna Investments Inc. New acquired a new position in Procter & Gamble Company (The) during the fourth quarter worth about $8,507,000. Institutional investors and hedge funds own 59.48% of the company’s stock.

Shares of Procter & Gamble Company (NYSE:PG) traded down 0.103% on Thursday, hitting $92.345. 1,691,275 shares of the company traded hands. Procter & Gamble Company has a 12 month low of $81.18 and a 12 month high of $92.95. The company has a market capitalization of $235.48 billion, a PE ratio of 16.511 and a beta of 0.68. The stock’s 50-day moving average price is $89.30 and its 200-day moving average price is $89.05.

Procter & Gamble Company (The) (NYSE:PG) last released its quarterly earnings results on Thursday, July 27th. The company reported $0.85 EPS for the quarter, beating the consensus estimate of $0.78 by $0.07. Procter & Gamble Company (The) had a net margin of 23.56% and a return on equity of 19.97%. The firm had revenue of $16.08 billion during the quarter, compared to the consensus estimate of $16.01 billion. During the same quarter in the prior year, the firm earned $0.79 EPS. Procter & Gamble Company (The)’s revenue for the quarter was down .1% on a year-over-year basis. On average, equities analysts predict that Procter & Gamble Company will post $4.17 earnings per share for the current year.

The firm also recently declared a quarterly dividend, which was paid on Tuesday, August 15th. Investors of record on Friday, July 21st were given a $0.6896 dividend. The ex-dividend date of this dividend was Wednesday, July 19th. This represents a $2.76 annualized dividend and a yield of 2.98%. Procter & Gamble Company (The)’s dividend payout ratio (DPR) is 49.37%.

PG has been the topic of a number of recent research reports. Royal Bank Of Canada reiterated a “hold” rating and set a $80.00 price objective on shares of Procter & Gamble Company (The) in a research note on Monday, April 24th. Jefferies Group LLC reiterated a “buy” rating and set a $103.00 price objective on shares of Procter & Gamble Company (The) in a research note on Wednesday, April 26th. Vetr upgraded shares of Procter & Gamble Company (The) from a “hold” rating to a “buy” rating and set a $94.67 price objective on the stock in a research note on Wednesday, April 26th. Stifel Nicolaus dropped their price objective on shares of Procter & Gamble Company (The) from $88.00 to $87.00 and set a “hold” rating on the stock in a research note on Thursday, April 27th. Finally, UBS AG reiterated a “buy” rating and set a $102.00 price objective (down from $104.00) on shares of Procter & Gamble Company (The) in a research note on Friday, April 28th. Three research analysts have rated the stock with a sell rating, eleven have issued a hold rating and seven have given a buy rating to the company. The company presently has a consensus rating of “Hold” and a consensus target price of $87.48.

In related news, insider Patrice Louvet sold 29,621 shares of the company’s stock in a transaction on Friday, May 19th. The shares were sold at an average price of $86.01, for a total value of $2,547,702.21. Following the completion of the sale, the insider now owns 76,651 shares in the company, valued at approximately $6,592,752.51. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, insider Suranjan Magesvaran sold 10,512 shares of the company’s stock in a transaction on Monday, July 31st. The shares were sold at an average price of $91.00, for a total transaction of $956,592.00. The disclosure for this sale can be found here. In the last quarter, insiders sold 141,548 shares of company stock valued at $12,287,453. 0.35% of the stock is owned by insiders.

Procter & Gamble Company (The) Company Profile

The Procter & Gamble Company is focused on providing branded consumer packaged goods to the consumers across the world. The Company operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care, and Baby, Feminine & Family Care. The Company sells its products in approximately 180 countries and territories primarily through mass merchandisers, grocery stores, membership club stores, drug stores, department stores, distributors, baby stores, specialty beauty stores, e-commerce, high-frequency stores and pharmacies.

Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Procter & Gamble Company (The) (NYSE:PG).